Effect of Neuroscience-based Pain Education associated with Cyclobenzaprine administration in patients with Masticatory Myofascial Pain: a double blind randomized controlled clinical trial

niversidade Federal de Minas Gerais0 个研究点开始时间: 2023年8月11日最近更新: 2023年8月22日

适应症

试验速览

暂无简介。

•Women; aged 18 to 60 years; diagnosed with muscular temporomandibular disorder or masticatory myofascial pain according to the Diagnostic Criteria for Temporomandibular Disorders; pain greater than or equal to 4 on the Visual Numerical Scale for at least 3 months

•History of recent facial trauma within the past 2 years; gestation; continuous use of non-steroidal anti-inflammatory drugs, analgesics, antidepressants or muscle relaxants; intracranial, neurological disorders and other major causes of headache; odontogenic pain; persistent idiopathic dentoalveolar pain; orthodontics; other current treatment for temporomandibular disorders; diagnosis of fibromyalgia; hypersensitivity to cyclobenzaprine or any other component of the product's formula; any contraindication provided in the package insert for the use of cyclobenzaprine; non-acceptance to voluntarily participate in the research or refusal to sign the informed consent form

发起方

niversidade Federal de Minas Gerais